Filing Details

Accession Number:
0001437749-17-020756
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-15 14:34:19
Reporting Period:
2017-12-13
Accepted Time:
2017-12-15 14:34:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
768710 Reliv International Inc RELV Pharmaceutical Preparations (2834) 371172197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
902108 L Robert Montgomery 136 Chesterfield Industrial Boulevard
Chesterfield MO 63005
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Reliv International, Inc. Acquisiton 2017-12-13 1,200 $4.49 526,727 No 4 P Indirect IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect IRA
Footnotes
  1. 1. Purchased pursuant to Rule 10B5-1 Plan